Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Grail
company
About
Grail develops a pan-cancer screening test designed to detect cancers at an early stage.
- 501 - 1000
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $300M
- Industries
- Biotechnology,Health Care,Health Diagnostics,Medical,Medical Device
- Founded date
- Jan 1, 2016
- Number Of Employee
- 501 - 1000
- Operating Status
- Active
Grail develops a pan-cancer screening test designed to detect cancers at an early stage. Its pan-cancer screening test measures circulating nucleic acids in blood using high-intensity sequencing, population-scale clinical trials, enabling doctors to develop blood tests for early-stage cancer detection.The company was founded in 2016 by Alex Aravanis and Jeff Huber in Menlo Park, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$1.61B
Grail has raised a total of
$1.61B
in funding over 2 rounds. Their latest funding was raised on
May 21, 2018 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 21, 2018 | Series C | $300M | 1 | — | — | Detail |
| Mar 1, 2017 | Series B | $1.21B | 1 |
ARCH Venture Partners
|
— | Detail |
| Jan 12, 2016 | Series A | $100M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Grail is funded by 2 investors.
ARCH Venture Partners
and China Merchants Securities
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
ARCH Venture Partners
|
Yes | Series B |
China Merchants Securities
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
